The cyclin-dependent kinase inhibitors p18(INK4c) and p19(INK4d) are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 644-651

  Tschan, M P ^a   Peters, U R ^c   Cajot, J F ^a,b   Betticher, D C ^a,b   Fey, M F ^a,b   Tobler, A ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

AML; Cell cycle; CKI; Differentiation; Stem cells

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ANTIGENS, CD34; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P19; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032828743     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01617.x     Document Type: Article

References (33)

1. Asada, M., Yamada, T., Fukumuro, K. & Mizutani, S. (1998) p21Cip1/WAF1 is important for differentiation and survival of U937 cells. Leukemia, 12, 1944-1950.
2. Asou, H., Koike, M., Elstner, E., Cambell, M., Le, J., Uskokovic, M.R., Kamada, N. & Koeffler, H.P. (1998) 19-nor vilamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. Blood, 92, 2441-2449.
3. Banker, D.E., Groudine, M., Willman, C.L., Norwood, T. & Appelbaum, F.R. (1998) Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents. Leukemia Research, 22, 221-239.
4. Carroll, M., Zhu, Y. & D'Andrea, A.D. (1995) Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Proceedings of the National Academy of Sciences of the United States of America, 92, 2869-2873.
5. Ciaparrone, M., Yamamoto, H., Yao, Y., Sgambato, A., Cattoretti, G., Tomita, N., Monden, T., Rotterdam, H. & Weinstein, I.B. (1998) Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Research, 58, 114-122.
6. Colotta, F., Peri, G., Villa, A. & Mantovani, A. (1984) Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. Journal of Immunology, 132, 936-944.
7. Dodge, J.E., List, A.F. & Futscher, B.W. (1998) Selective variegated methylation of the p15 CpG island in acute rnyeloid leukemia. International Journal of Cancer, 78, 561-567.
8. Ferrari, S., Calabretta, B., Selleri, L., Ceccherelli, G., Torelli, G. & Torelli, U. (1988) Expression of oncogenes and cell cycle related genes in acute and chronic leukemias. Leukemia, 2, 160S-166S.
9. Franklin, D.S., Godfrey, V.L., Lee, H., Kovalev, G.I., Schoonhoven, R., Chen-Kiang, S., Su, L. & Xiong, Y. (1998) CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes and Development, 12, 2899-2911.
10. Hatta, Y., Spirin, K., Tasaka, T., Morosetti, R., Said, J.W., Yamada, Y., Tomonaga, M. & Koeffler, H.P. (1997) Analysis of p18INK4C in adult T-cell leukaemia and non-Hodgkin's lymphoma. British Journal of Haematology, 99, 665-667.
11. Hauser, P.J., Agrawal, D., Flanagan, M. & Pledger, W.J. (1997) The role of p27kip1 in the in vitro differentiation of murine keratinocytes. Cell Growth and Differentiation, 8, 203-211.
12. Herman, J.G., Civin, C.I., Issa, J.P., Collector, M.I., Sharkis, S.J. & Baylin, S.B. (1997) Distinct patterns of inadivation of p1 5INK4B and p161NK4A characterize the major types of hematological malignancies. Cancer Research, 57, 837-841.
13. Hirai, H., Roussel, M.F., Kato, J.Y., Ashmun, R.A. & Sherr, C.J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Molecular and Cellular Biology, 15, 2672-2681.
14. Jiang, H., Lin, J., Su, Z.Z., Collart, F.R., Huberman, E. & Fisher, P.B. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9, 3397-3406.
15. Larison, K.D., BreMiller, R., Wells, K.S., Clements, I. & Haugland, R.P. (1995) Use of a new fluorogenic phosphatase substrate in immunohistochemical applications. Journal of Histochemistry and Cytochemistry, 43, 77-83.
16. Lee, M.H., Reynisdottir, I. & Massague, J. (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes and Development, 9, 639-649.
17. Macleod, K.F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B. & Jacks, T. (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes and Development, 9, 935-944.
18. Matsuoka, S., Edwards, M.C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J.W. & Elledge, S.J. (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes and Development, 9, 650-662.
19. Nakamaki, T., Bartram, C., Seriu, T., Kahan, J., Fukuchi, K., Tsuruoka, N., Janssen, J.W., Miller, C.W. & Koeffler, H.P. (1997) Molecular analysis of the cyclic-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes. Leukemia Research, 21, 235-240.
20. Olsson, I., Bergh, G., Ehinger, M. & Gullberg, U. (1996) Cell differentiation in acute myeloid leukaemia. European Journal of Haematology, 57, 1-16.
21. Ruas, M. & Peters, G. (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochimica et Biophysica Acta, 1378, F115-F177.
22. Schwaller, J., Pabst, T., Bickel, M., Borisch, B., Fey, M.F. & Tobler, A. (1997a) Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16beta, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT-PCR using a polycompetitive internal standard. British Journal of Haematology, 99, 896-900.
23. Schwaller, J., Pabst, T., Koeffler, H.P., Niklaus, G., Loetscher, P., Fey, M.F. & Tobler, A. (1997) Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK40, p19INK4D) in human acute myeloid leukemia and normal myeloid cells. Leukemia, 11, 54-63.
24. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
25. Shiohara, M., Spirin, K., Said, J.W., Gombart, A.F., Nakamaki, T., Takeuchi, S., Hatta, Y., Morosetti, R., Tasaka, T., Seriu, T., Bartram, C., Miller, C.W., Tomonaga, M. & Koeffler, H.P. (1996) Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies. Leukemia, 10, 1897-1900.
26. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A. & el-Houseini, M.E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9, 3389-3396.
27. Teofili, L., Rutella, S., Chiusolo, P., La Barbera, E.O., Rumi, C., Ranelleti, F.O., Maggiano, N., Leone, G. & Larocca, L.M. (1998) Expression of p15INK4B in normal hematopoiesis. Experimental Hematology, 26, 1133-1139.
28. Wang, Q.M., Chen, F., Luo, X., Moore, D.C., Flanagan, M. & Studzinski, G.P. (1998) Lowering of p27Kip1 levels by its antisense or by development of resistance to 1,25-dihydroxyvitamin D3 reverses the G1 block but not differentiation of HL60 cells. Leukemia, 12, 1256-1265.
29. Wann, Z., Su, Z.Z., Fisher, P.B., Wang, S., VanTuyle, G. & Grant, S. (1998) Evidence of a functional role for the cyclin-dependent kinase inhibitor p21 (WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells. Experimental Cell Research, 244, 105-116.
30. Yaroslavskiy, B., Watkins, S., Donnenberg, A.D., Patton, T.J. & Steinman, R.A. (1999) Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood, 93, 2907-2917.
31. Zariwala, M. & Xiong, Y. (1996) Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors. Oncogene, 13, 2033-2038.
32. Zhang, P., Wong, C., DePinho, R.A., Harper, J.W. & Elledge, S.J. (1998) Cooperation between the cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes and Development, 12, 3162-3167.
33. Zhang, W., Kornblau, S.M., Kobayashi, T., Gambel, A., Claxton, D. & Deisseroth, A.B. (1995) High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clinical Cancer Research, 1, 1051-1057.